Guy P. Nohra
CIK: 0001198330
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (7 total)
- Jun 9, 2026TELA
TELA Bio, Inc.
Award(A)Direct11.7K shares- - Jun 9, 2026TELA
TELA Bio, Inc.
Award(A)Direct11.9K shares- - Jun 3, 2026BVS
Bioventus Inc.
Award(A)DirectRestricted Stock Units
25.1K shares- - Jun 2, 2026BVS
Bioventus Inc.
Exercise(M)Direct32.3K shares- - Dec 4, 2025BVS
Bioventus Inc.
Sale(S)Direct10K shares at avg. $7.57$76K - Jun 3, 2025BVS
Bioventus Inc.
Award(A)DirectRestricted Stock Units
32.3K shares- - Jun 2, 2025BVS
Bioventus Inc.
Exercise(M)Direct26.5K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 9, 2026 |  TELA TELA Bio, Inc. | Award(A) | 11,675 | - | $0 | Direct |
| Jun 9, 2026 | TELA TELA Bio, Inc. | Award(A) | 11,925 | - | $0 | Direct |
| Jun 3, 2026 |  BVS Bioventus Inc. | Award(A) Restricted Stock Units | 25,146 | - | - | Direct |
| Jun 2, 2026 | BVS Bioventus Inc. | Exercise(M) | 32,282 | - | $0 | Direct |
| Dec 4, 2025 | BVS Bioventus Inc. | Sale(S) | 10,000 | $7.57 | $75,658 | Direct |
| Jun 3, 2025 | BVS Bioventus Inc. | Award(A) Restricted Stock Units | 32,282 | - | - | Direct |
| Jun 2, 2025 | BVS Bioventus Inc. | Exercise(M) | 26,493 | - | - | Direct |
1-7 of 7 transactions
About NOHRA GUY P
NOHRA GUY P (SEC CIK 0001198330) files insider reports with the SEC as Director of TELA Bio, Inc. (TELA) and Director of Bioventus Inc. (BVS).
Signal8 holds 5 ownership filings by NOHRA GUY P (1 Form 3, 4 Form 4), filed between Jun 4, 2025 and Jun 11, 2026. Those filings report 7 transactions, from Jun 2, 2025 to Jun 9, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on NOHRA GUY P's filings is in DURHAM, NC.
Recent filings by NOHRA GUY P
- Jun 9, 2026: Grants or awards of TELA shares (2 lines, Form 4, code A).
- Jun 3, 2026: Grant or award of BVS derivative securities (Form 4, code A).
- Jun 2, 2026: Option exercise of BVS shares (Form 4, code M).
- Dec 4, 2025: Open-market sale of BVS shares (Form 4, code S).
- Jun 3, 2025: Grant or award of BVS derivative securities (Form 4, code A).
Other insiders filing for TELA Bio, Inc. (TELA)
- Capper Joseph H, Director
- Plovanic William J., Director
- Getz Heather C, Chief Executive Officer
- Rocchio Betty Jo, Director
- NEELS GUIDO J, Director
- THOMAS PAUL, Director